Evidence map›Paper›PMID 24565357›Full record

Trial reportJournal of the American Academy of Child and Adolescent Psychiatry2014

24- and 36-week outcomes for the Child/Adolescent Anxiety Multimodal Study (CAMS).

John Piacentini, Shannon Bennett, Scott N Compton, Phillip C Kendall, Boris Birmaher, Anne Marie Albano, John March, Joel Sherrill, Dara Sakolsky, Golda Ginsburg and 7 more

2 registry-linked trialsAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Journal of the American Academy of Child and Adolescent Psychiatry, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 61 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
61citing papers in PubMed, 6 pooled it
13.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00052078 phase3completednot on this map

Child/Adolescent Anxiety Multimodal Treatment Study

TypeinterventionalSponsorJohns Hopkins UniversityRan2003 to 2008Enrolled488ConditionsAnxiety Disorders, Social Phobia, Generalized Anxiety DisorderArmsSertraline (SRT), Cognitive Behavioral Therapy (CBT), Placebo
NCT04598230 phase3active not recruitingnot on this mapstarted 2021, after this paper: background citation

Partners in Caring for Anxious Youth

TypeinterventionalSponsorAnn & Robert H Lurie Children's Hospital of ChicagoRan2021 to 2026Enrolled468ConditionsAnxiety, Separation, Anxiety, Generalized, Anxiety, SocialArmsCognitive Behavioral Therapy (CBT), Combination therapy (COMB)
3 · Its place in the literature

Who cites it

61 citing papers in PubMed, 6 syntheses or guidelines pooled it, 157 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Trial
  8. Trial
  9. Trial
  10. Brief Behavioral Therapy for Pediatric Anxiety and Depression in Primary Care: A Follow-up.Journal of the American Academy of Child and Adolescent Psychiatry · 2020
    Trial
  11. Trial
  12. Trial
  13. Trial
  14. Trial
  15. Trial
  16. Trial
  17. Trial
  18. Trial
  19. Trial
  20. Improving Transition to Adulthood for Students with Autism: A Randomized Controlled Trial of STEPS.Journal of clinical child and adolescent psychology : the official journal for the Society of Clinical Child and Adolescent Psychology, American Psychological Association, Division 53
    Trial

1 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

17 authors at 10 institutions in 2 countries.

John PiacentiniUniversity of California-Los Angeles (UCLA) Semel Institute for Neuroscience and Human Behavior. Electronic address: jpiacentini@mednet.ucla.edu.
Shannon BennettWeill Cornell Medical College.
Scott N ComptonDuke University Medical Center.
Phillip C KendallTemple University.
Boris BirmaherWestern Psychiatric Institute and Clinic-University of Pittsburgh Medical Center.
Anne Marie AlbanoNew York State Psychiatric Institute-Columbia University Medical Center.
John MarchDuke University Medical Center.
Joel SherrillDivision of Services and Intervention Research, National Institute of Mental Health (NIMH).
Dara SakolskyWestern Psychiatric Institute and Clinic-University of Pittsburgh Medical Center.
Golda GinsburgJohns Hopkins Medical Institutions.
Moira RynnNew York State Psychiatric Institute-Columbia University Medical Center.
R Lindsey BergmanUniversity of California-Los Angeles (UCLA) Semel Institute for Neuroscience and Human Behavior.
Elizabeth GoschPhiladelphia College of Osteopathic Medicine.
Bruce WaslickBaystate Medical Center.
Satish IyengarWestern Psychiatric Institute and Clinic-University of Pittsburgh Medical Center.
James McCrackenUniversity of California-Los Angeles (UCLA) Semel Institute for Neuroscience and Human Behavior.
John WalkupWeill Cornell Medical College.
University of California, Los Angeles · USUniversity of Pittsburgh Medical Center · USColumbia University Irving Medical Center · USCornell University · USDuke Medical Center · USBaystate Medical Center · USJohns Hopkins University · USNational Institute of Mental Health · CZPhiladelphia College of Osteopathic Medicine · USTemple University · US

Funding

Child/Adolescent Anxiety Multimodal Treatment StudyU01MH064089 · NIMH · JOHNS HOPKINS UNIVERSITY · PI GINSBURG, GOLDA SUSAN · 2002 to 2007
$3.1M
Child/Adolescent Anxiety Multimodal Treatment StudyU01MH064003 · NIMH · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI BIRMAHER, BORIS · 2002 to 2007
$2.7M
Child/Adolescent Anxiety Multimodal Treatment Study (CAMS)U01MH064092 · NIMH · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI ALBANO, ANNE MARIE · 2002 to 2007
$2.4M
Child and Adolescent Anxiety Multisite Study (CAMS)U01MH064107 · NIMH · DUKE UNIVERSITY · PI MARCH, JOHN S · 2002 to 2007
$2.4M
Child/Adolescent Anxiety Multimodal Treatment StudyU01MH063747 · NIMH · TEMPLE UNIV OF THE COMMONWEALTH · PI KENDALL, PHILIP C · 2002 to 2007
$2.2M
Child/Adolescent Anxiety Multimodal Treatment StudyU01MH064088 · NIMH · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI PIACENTINI, JOHN C. · 2002 to 2007
$2.1M
NIMH NIH HHS L40 MH072315NIMH NIH HHS U01 MH063747NIMH NIH HHS U01 MH064003NIMH NIH HHS U01 MH064088NIMH NIH HHS U01 MH064089NIMH NIH HHS U01 MH064092NIMH NIH HHS U01 MH064107NIMH NIH HHS U01 MH63747NIMH NIH HHS U01 MH64003NIMH NIH HHS U01 MH64088NIMH NIH HHS U01 MH64092NIMH NIH HHS U01 MH64107
6 · The paper itself

Abstract

objectiveWe report active treatment group differences on response and remission rates and changes in anxiety severity at weeks 24 and 36 for the Child/Adolescent Anxiety Multimodal Study (CAMS).

methodCAMS youth (N = 488; 74% ≤ 12 years of age) with DSM-IV separation, generalized, or social anxiety disorder were randomized to 12 weeks of cognitive-behavioral therapy (CBT), sertraline (SRT), CBT+SRT (COMB), or medication management/pill placebo (PBO). Responders attended 6 monthly booster sessions in their assigned treatment arm; youth in COMB and SRT continued on their medication throughout this period. Efficacy of COMB, SRT, and CBT (n = 412) was assessed at 24 and 36 weeks postrandomization. Youth randomized to PBO (n = 76) were offered active CAMS treatment if nonresponsive at week 12 or over follow-up and were not included here. Independent evaluators blind to study condition assessed anxiety severity, functioning, and treatment response. Concomitant treatments were allowed but monitored over follow-up.

resultsThe majority (>80%) of acute responders maintained positive response at both weeks 24 and 36. Consistent with acute outcomes, COMB maintained advantage over CBT and SRT, which did not differ, on dimensional outcomes; the 3 treatments did not differ on most categorical outcomes over follow-up. Compared to COMB and CBT, youth in SRT obtained more concomitant psychosocial treatments, whereas those in SRT and CBT obtained more concomitant combined (medication plus psychosocial) treatment.

conclusionsCOMB maintained advantage over CBT and SRT on some measures over follow-up, whereas the 2 monotherapies remained indistinguishable. The observed convergence of COMB and monotherapy may be related to greater use of concomitant treatment during follow-up among youth receiving the monotherapies, although other explanations are possible. Although outcomes were variable, most CAMS-treated youth experienced sustained treatment benefit. Clinical trial registration information-Child and Adolescent Anxiety Disorders (CAMS); URL: http://clinicaltrials.gov. Unique identifier: NCT00052078.

Indexed as

AdolescentAnxiety DisordersChildCognitive Behavioral TherapyCombined Modality TherapyFemaleHumansMalePlacebosSelective Serotonin Reuptake InhibitorsSertralineTime FactorsTreatment OutcomePlacebosSelective Serotonin Reuptake InhibitorsSertralineanxietyChild/Adolescent Anxiety Multimodal Study (CAMS)cognitive-behavioral therapy (CBT)follow-upselective serotonin reuptake inhibitor (SSRI)

Identifiers

PMID24565357
PMCPMC3982864
OpenAlexW2059569234

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.